Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market to hit $7.64B by 2031, DataM Intelligence
Global MASH Therapeutics Market Set to Reach $7.64B by 2031 AUSTIN, TX, UNITED STATES, November 12, 2025 /EINPresswire.com/ -- Market Size and Growth According to DataM Intelligence, the Metabolic Dysfunction-Associated Steatohepatitis (MASH) …